Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperbaric bupivacaine 9 mg versus 11 mg for spinal anesthesia in elective cesarean section
PACTR202209703705086Not yet recruiting
- Sponsor
- Agnes Morosi
- Start
- Jan 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of hyperbaric bupivacaine in pregnancy (2 arms), sponsored by Agnes Morosi. Primary endpoints: Hemodynamic changes after spinal block and Duration of spinal block. Planned start Jan 2023; status: not yet recruiting.
02
Drugs
hyperbaric bupivacaine
03
Conditions
pregnancy
Beyond the preview
Go deeper on PACTR202209703705086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202209703705086.